Evidence map›Paper›PMID 31197890›Full record

ReviewActa paediatrica (Oslo, Norway : 1992)2019

Paediatricians play a key role in preventing early harmful events that could permanently influence the development of the gut microbiota in childhood.

Olivier Goulet, Iva Hojsak, Sanja Kolacek, Tudor Lucian Pop, Fugen Cullu Cokugras, Gianvincenzo Zuccotti, Massimo Pettoello-Mantovani, Valentina Fabiano

Open access · bronzeAbstract readReview
In one paragraph

Review in Acta paediatrica (Oslo, Norway : 1992), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Effects ofArchives of medical science : AMS · 2023
    Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 6 countries.

Olivier GouletDepartment of Paediatric Gastroenterology, Hepatology and Nutrition, Intestinal Failure Rehabilitation Centre, National Reference Centre for Rare Digestive Diseases, APHP Necker-Enfants Malades Hospital, Paris-Descartes University, Paris, France.
Iva HojsakChildren's Hospital Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.ORCID 0000-0003-3262-5964
Sanja KolacekChildren's Hospital Zagreb, University of Zagreb School of Medicine, Zagreb, Croatia.
Tudor Lucian PopSecond Paediatric Clinic, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Romania.ORCID 0000-0002-4931-1219
Fugen Cullu CokugrasPaediatric Gastroenterology, Hepatology and Nutrition, Cerrahpas_a Medical Faculty, Istanbul University, Istanbul, Turkey.
Gianvincenzo ZuccottiPediatric Department, Vittore Buzzi Children's Hospital, Università degli Studi di Milano, Milan, Italy.
Massimo Pettoello-MantovaniDepartment of Pediatrics, Scientific Institute 'Casa Sollievo della Sofferenza', University of Foggia, Foggia, Italy.ORCID 0000-0002-0688-1131
Valentina FabianoPediatric Department, Vittore Buzzi Children's Hospital, Università degli Studi di Milano, Milan, Italy.ORCID 0000-0001-6449-1724
University of Milan · ITUniversity of Zagreb · HRHôpital Necker-Enfants Malades · FRIstanbul University · TRIuliu Hațieganu University of Medicine and Pharmacy · ROUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe development of the gut microbiota occurs primarily during infancy, and growing evidence has emphasised its positive role and implications for human health. The aim of this review was to provide essential knowledge about the gut microbiota and to describe and highlight the importance of the factors that influence the gut microbiota in early life and their potential harmful effects later in life.

methodsThe European Paediatric Association, the Union of the National European Paediatric Societies and Associations, convened a panel of independent European experts to summarise the research on microbiota for general paediatricians. They used PubMed and the Cochrane Library to identify studies published in English up to June 2018.

resultsA number of clinical conditions can disrupt the development of a stable gut microbiota. Changes in the microbiome have been documented in many chronic diseases, mainly immune-mediated gastrointestinal and liver diseases, and distinct patterns have been associated with each specific disease. The gut microbiota can be positively modulated with probiotics, prebiotics, synbiotics, paraprobiotics and postbiotics.

conclusionPaediatricians can play a key role in preventing harmful events that could permanently influence the composition and/or function of the gut microbiota. Various treatment strategies can be used.

Indexed as

Gastrointestinal MicrobiomePediatricsPhysician's RolePrimary PreventionAge FactorsHumansInfantInfant, NewbornDysbiosisGut microbiotaPrebioticsProbioticsSynbiotics

Identifiers

PMID31197890
PMCPMC6852013
OpenAlexW2949154673

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.